Pharmagreen Biotech Inc. (PHBI) Financial Statements (2025 and earlier)

Company Profile

Business Address 2987 BLACKBEAR COURT
COQUITLAM, BC V3E3A2
State of Incorp. NV
Fiscal Year End September 30
Industry (SIC) 4581 - Airports, Flying Fields, and Airport Terminal Services (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

6/30/2023
MRQ
9/30/2022
9/30/2021
9/30/2020
9/30/2019
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments8251263
Cash and cash equivalent8251263
Receivables   57
Inventory, net of allowances, customer advances and progress billings    
Inventory    
Other undisclosed current assets  25470
Total current assets:825266189
Noncurrent Assets
Property, plant and equipment    441
Other undisclosed noncurrent assets    
Total noncurrent assets:   441
Other undisclosed assets 201348  
TOTAL ASSETS:209373266630
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:725659540856
Interest and dividends payable808426
Accounts payable645580455830
Other undisclosed accounts payable and accrued liabilities80   
Debt21919168175
Derivative instruments and hedges, liabilities2714721,381 
Due to related parties 642605509476
Other undisclosed current liabilities55995657
Total current liabilities:1,9122,0263,1671,463
Noncurrent Liabilities
Long-term debt and lease obligation 2939302
Long-term debt, excluding current maturities 2939302
Liabilities, other than long-term debt 90   
Due to related parties 90   
Other undisclosed noncurrent liabilities  3 
Total noncurrent liabilities:11939332
Total liabilities:2,0322,0663,2001,465
Equity
Equity, attributable to parent, including:(1,823)(1,693)(2,888)(833)
Preferred stock00  
Common stock4423819676
Common stock, value, subscriptions 1   
Additional paid in capital10,2629,6813,9673,773
Accumulated other comprehensive income (loss)94(8)3748
Accumulated deficit(12,575)(11,699)(7,167)(4,729)
Other undisclosed equity, attributable to parent (47)(47)180 
Equity, attributable to noncontrolling interest  (47)(1)
Other undisclosed equity  47  
Total equity:(1,823)(1,646)(2,934)(834)
Other undisclosed liabilities and equity  (47)  
TOTAL LIABILITIES AND EQUITY:209373266630

Income Statement (P&L) ($ in thousands)

6/30/2023
TTM
9/30/2022
9/30/2021
9/30/2020
9/30/2019
Revenues216   
Gain (loss) on disposition of assets for financial service operations216(3,257)(1,149) 
Cost of revenue
(Cost of Product and Service Sold)
    
Gross profit:216   
Operating expenses(1,101)(744)(486)(646)
Other undisclosed operating income (loss)(216)3,2571,149 
Operating loss:(1,101)(744)(486)(646)
Nonoperating income (expense)226(3,788)(1,997)(123)
Investment income, nonoperating   (435) 
Gain (loss), foreign currency transaction, before tax(102)45  
Interest and debt expense(29)(681)(299) 
Loss from continuing operations before equity method investments, income taxes:(904)(5,213)(2,782)(769)
Other undisclosed income from continuing operations before income taxes   299 
Loss from continuing operations before income taxes:(904)(5,213)(2,483)(769)
Other undisclosed income from continuing operations  681  
Loss from continuing operations:(904)(4,532)(2,483)(769)
Loss before gain (loss) on sale of properties:(4,532)(2,483)(769)
Other undisclosed net income (loss)29(0)  
Net loss:(876)(4,532)(2,483)(769)
Net income attributable to noncontrolling interest  451
Other undisclosed net loss attributable to parent    
Net loss available to common stockholders, diluted:(876)(4,532)(2,438)(768)

Comprehensive Income ($ in thousands)

6/30/2023
TTM
9/30/2022
9/30/2021
9/30/2020
9/30/2019
Net loss:(876)(4,532)(2,483)(769)
Other undisclosed comprehensive income   3310
Comprehensive loss:(876)(4,532)(2,450)(758)
Comprehensive income (loss), net of tax, attributable to noncontrolling interest(978)(4,577)451
Other undisclosed comprehensive loss, net of tax, attributable to parent    
Comprehensive loss, net of tax, attributable to parent:(1,853)(9,109)(2,405)(757)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: